Identity & Access Management Provider BIO-key’s MobileAuthTM with PalmPositiveTM
Wins Lucintel 2021 Technology Innovation Award in the Biometric Market
Wall, NJ - July 15, 2021 - BIO-key International, Inc. (NASDAQ: BKYI), an innovative providerof workforce and customer identity and access management (IAM) solutions featuring IdentityBound Biometrics, today announced its BIO-key MobileAuth™ with PalmPositive™ solution has
been selected as the winner of the 2021 Technology Innovation Award in the Biometric Market,
conducted by Lucintel, a premier market research, and management consulting firm. This newmobile application is the latest among over sixteen strong authentication factors available for
BIO-key’s PortalGuard® Identity-as-a-Service (IDaaS) platform that aims to obsolete traditional
authentication methods.
Based on recent market research, Lucintel chose BIO-key MobileAuth for this award because of
its novel approach to multi-factor authentication. MobileAuth offers fast, touchless IdentityBound Biometric user authentication – using a palm scan – that works on any camera-equipped
device, supporting both Android and iOS, to provide the unique combination of a simple andconvenient user experience with the highest levels of security and flexibility enterprises need.
With MobileAuth, BIO-key has introduced a different way to authenticate that eliminates theinconvenience, security risks, and costs of traditional authentication methods. Well-suited foreveryday use cases including secure remote access for the workforce, third-party access,Customer IAM (CIAM), and passwordless workflows, MobileAuth offers Identity-Bound
Biometrics as an alternative to user-controlled, device-based biometric methods, ensuring that
only an authentic user can access their online identity, preventing information from being
accessed by unauthorized users or hackers.
“We’re honored that Lucintel awarded BIO-key MobileAuth with its Technology Innovation
Award in the biometric sector. This continues to confirm that by offering this different way toauthenticate among our other flexible authentication options, we’re giving the enterprise a moreaccurate, secure, convenient authentication method that provides the level of integrity theyrequire,” said Michael DePasquale, Chairman and CEO of BIO-key International.
Lucintel’s awards in innovation and industry excellence recognize outstanding achievements
and the latest endeavors by companies in various industries, identifying the most successful,
innovative, and forward-thinking companies and products in business today. Lucintel awards are
based on systematic and detailed research on the market to identify and recognize the mostsuccessful recent innovations or industry excellences that demonstrate high levels of industry
impact and benefits to end users.
Learn more about BIO-key MobileAuth with PalmPositive by visiting the BIO-key website.

About Lucintel
Lucintel, a premier market research and management consulting firm based in Dallas, Texas,
has served over 1,000 clients for over 20 years. With in-depth analysis and sage advice,
Lucintel offers solutions for your growth through game-changing ideas and analysis of robust
markets and unmet needs. Lucintel has been quoted in esteemed publications including The
Wall Street Journal, ZACKS and The Financial Times.
About BIO-key International, Inc. (www.bio-key.com)
BIO-key has over two decades of expertise in providing authentication technology for thousandsof organizations and millions of users and is revolutionizing authentication with biometric-centric,
multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM
solution, that provides convenient and secure access to devices, information, applications, andhigh-value transactions. BIO-key's patented software and hardware solutions, with industryleading biometric capabilities, enable large-scale on-premises and Identity-as-a-Service (IDaaS)
solutions as well as customized enterprise and cloud solutions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are"forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995
(the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes," andsimilar expressions are intended to identify forward-looking statements. Such forward-looking
statements are made based on management's beliefs, as well as assumptions made by, andinformation currently available to, management pursuant to the "safe harbor" provisions of theAct. These statements are not guarantees of future performance or events and are subject torisks and uncertainties that may cause actual results to differ materially from those included
within or implied by such forward-looking statements. These risks and uncertainties include,
without limitation, our history of losses and limited revenue; our ability to raise additional capital;
our ability to protect our intellectual property; changes in business conditions; changes in oursales strategy and product development plans; changes in the marketplace; continued servicesof our executive management team; security breaches; competition in the biometric technology
industry; market acceptance of biometric products generally and our products underdevelopment; our ability to execute and deliver on contracts in Africa; our ability to expand into
Asia, Africa and other foreign markets; the duration and severity of the current coronavirus
COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and thegeographic markets in which we operate; delays in the development of products and statementsof assumption underlying any of the foregoing as well as other factors set forth under thecaption see "Risk Factors'' in our Annual Report on Form 10-K for the year ended December 31,
2020 and other filings with the Securities and Exchange Commission. Readers are cautioned
not to place undue reliance on these forward-looking statements, which speak only as of thedate made. Except as required by law, the Company undertakes no obligation to disclose any
revision to these forward-looking statements whether as a result of new information, future
events, or otherwise. Additionally, there may be other factors of which the Company is not
currently aware that may affect matters discussed in forward-looking statements and may also
cause actual results to differ materially from those discussed. In particular, the consequences ofthe coronavirus outbreak to economic conditions and the industry in general and the financial
position and operating results of our Company, in particular, have been material, are changing
rapidly, and cannot be predicted.
Engage with BIO-key:
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/

LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIRBIO-key Media Contact:
Erin Knapp
Matter Communications
BIO-key@matternow.com
914-260-3158
Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800